Glaxosmithkline Pharmaceuticals Ltd Dividend History & Latest Dividend 2026

Glaxosmithkline Pharmaceuticals declared a final dividend of ₹57.00 per share on 13 May 2026, with a record date of 29 May 2026.

Shareholders on record as of 29 May 2026 are eligible for the Glaxosmithkline Pharmaceuticals dividend. It is credited to the bank account linked to the shareholder's demat account.

The ex-date is 29 May 2026 and the record date is 29 May 2026. Under the T+1 settlement cycle, investors generally need to buy shares before the ex-date to be eligible for the dividend.

Glaxosmithkline Pharmaceuticals has paid a dividend in each of the last 12 financial years, up to FY2026. In FY2026 its payout frequency was annual. It also declared a special dividend in 2024.

Glaxosmithkline Pharmaceuticals's trailing 12-month dividend yield is 2.09% as of 11 November 2026, based on ₹57.00 of dividends per share during the previous 12 months and a share price of ₹2,727.70.

Adjusted for 1:1 bonus in Sep 2018. A bonus issue or stock split increases the number of shares, so dividends paid before it are restated on today's share count to make them comparable with later payouts.

Dividends from Glaxosmithkline Pharmaceuticals are taxable as income from other sources at your applicable income tax slab rate. TDS at 10% is deducted at source if your total dividend income from Glaxosmithkline Pharmaceuticals exceeds ₹10,000 in a financial year. NRI investors are subject to 20% TDS or applicable DTAA rate. You can claim TDS credit when filing your ITR.

Check the bank account linked to your demat account for the dividend credit. Where applicable, tax deducted at source also appears in your Form 26AS and AIS.